Goldman Sachs’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.3M | Sell |
2,411,660
-723,813
| -23% | -$15.7M | 0.01% | 1110 |
|
|
2025
Q1 | $76M | Buy |
3,135,473
+333,100
| +12% | +$8.08M | 0.01% | 814 |
|
|
2024
Q4 | $58.5M | Buy |
2,802,373
+1,330,120
| +90% | +$27.8M | 0.01% | 976 |
|
|
2024
Q3 | $29.3M | Buy |
1,472,253
+384,122
| +35% | +$7.64M | ﹤0.01% | 1440 |
|
|
2024
Q2 | $16.9M | Buy |
1,088,131
+86,850
| +9% | +$1.35M | ﹤0.01% | 1708 |
|
|
2024
Q1 | $16M | Buy |
1,001,281
+42,868
| +4% | +$683K | ﹤0.01% | 1694 |
|
|
2023
Q4 | $16.1M | Sell |
958,413
-9,906
| -1% | -$167K | ﹤0.01% | 1735 |
|
|
2023
Q3 | $11.3M | Sell |
968,319
-282,209
| -23% | -$3.3M | ﹤0.01% | 1899 |
|
|
2023
Q2 | $16.8M | Buy |
1,250,528
+113,791
| +10% | +$1.53M | ﹤0.01% | 1675 |
|
|
2023
Q1 | $18.8M | Buy |
1,136,737
+372,774
| +49% | +$6.18M | ﹤0.01% | 1560 |
|
|
2022
Q4 | $14.2M | Buy |
763,963
+43,837
| +6% | +$815K | ﹤0.01% | 1859 |
|
|
2022
Q3 | $9.24M | Sell |
720,126
-1,190,538
| -62% | -$15.3M | ﹤0.01% | 2190 |
|
|
2022
Q2 | $13.4M | Buy |
1,910,664
+807,303
| +73% | +$5.66M | ﹤0.01% | 1899 |
|
|
2022
Q1 | $9.15M | Buy |
1,103,361
+381,435
| +53% | +$3.16M | ﹤0.01% | 2313 |
|
|
2021
Q4 | $4.89M | Buy |
721,926
+7,069
| +1% | +$47.9K | ﹤0.01% | 2819 |
|
|
2021
Q3 | $3.79M | Sell |
714,857
-353,290
| -33% | -$1.87M | ﹤0.01% | 2983 |
|
|
2021
Q2 | $6.14M | Sell |
1,068,147
-353,846
| -25% | -$2.03M | ﹤0.01% | 2629 |
|
|
2021
Q1 | $6.56M | Sell |
1,421,993
-1,800,597
| -56% | -$8.3M | ﹤0.01% | 2478 |
|
|
2020
Q4 | $10.8M | Buy |
3,222,590
+691,102
| +27% | +$2.31M | ﹤0.01% | 1998 |
|
|
2020
Q3 | $7.52M | Buy |
2,531,488
+461,248
| +22% | +$1.37M | ﹤0.01% | 2137 |
|
|
2020
Q2 | $9.56M | Buy |
2,070,240
+105,776
| +5% | +$489K | ﹤0.01% | 1971 |
|
|
2020
Q1 | $7.56M | Buy |
1,964,464
+37,469
| +2% | +$144K | ﹤0.01% | 1983 |
|
|
2019
Q4 | $7.23M | Buy |
1,926,995
+959,032
| +99% | +$3.6M | ﹤0.01% | 2214 |
|
|
2019
Q3 | $5.14M | Buy |
967,963
+906,407
| +1,472% | +$4.81M | ﹤0.01% | 2309 |
|
|
2019
Q2 | $236K | Sell |
61,556
-25,933
| -30% | -$99.4K | ﹤0.01% | 3805 |
|
|
2019
Q1 | $447K | Buy |
87,489
+34,679
| +66% | +$177K | ﹤0.01% | 3602 |
|
|
2018
Q4 | $101K | Sell |
52,810
-285,757
| -84% | -$547K | ﹤0.01% | 3885 |
|
|
2018
Q3 | $1.28M | Sell |
338,567
-120,395
| -26% | -$455K | ﹤0.01% | 3079 |
|
|
2018
Q2 | $1.43M | Buy |
458,962
+22,310
| +5% | +$69.6K | ﹤0.01% | 3028 |
|
|
2018
Q1 | $1.04M | Buy |
436,652
+70,274
| +19% | +$168K | ﹤0.01% | 3168 |
|
|
2017
Q4 | $1.43M | Buy |
366,378
+320,810
| +704% | +$1.25M | ﹤0.01% | 2987 |
|
|
2017
Q3 | $115K | Buy |
45,568
+26,716
| +142% | +$67.4K | ﹤0.01% | 4012 |
|
|
2017
Q2 | $52K | Buy |
18,852
+198
| +1% | +$546 | ﹤0.01% | 4243 |
|
|
2017
Q1 | $36K | Sell |
18,654
-24,325
| -57% | -$46.9K | ﹤0.01% | 4254 |
|
|
2016
Q4 | $45K | Sell |
42,979
-130,421
| -75% | -$137K | ﹤0.01% | 4238 |
|
|
2016
Q3 | $189K | Sell |
173,400
-16,207
| -9% | -$17.7K | ﹤0.01% | 3954 |
|
|
2016
Q2 | $135K | Buy |
189,607
+87,752
| +86% | +$62.5K | ﹤0.01% | 4022 |
|
|
2016
Q1 | $119K | Buy |
101,855
+73,958
| +265% | +$86.4K | ﹤0.01% | 3977 |
|
|
2015
Q4 | $68K | Buy |
+27,897
| New | +$68K | ﹤0.01% | 4101 |
|
|
2015
Q3 | – | Sell |
-11,942
| Closed | -$49K | – | 4572 |
|
|
2015
Q2 | $49K | Sell |
11,942
-90,982
| -88% | -$373K | ﹤0.01% | 4428 |
|
|
2015
Q1 | $446K | Buy |
102,924
+84,222
| +450% | +$365K | ﹤0.01% | 3389 |
|
|
2014
Q4 | $56K | Buy |
18,702
+6,482
| +53% | +$19.4K | ﹤0.01% | 4361 |
|
|
2014
Q3 | $41K | Buy |
+12,220
| New | +$41K | ﹤0.01% | 4396 |
|